Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Chronic Heart Failure

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    October 2025
  1. CATALANO MA, Edelson JB, Toubat O, Beqaj H, et al
    Contemporary outcomes and healthcare costs associated with single-ventricle heart failure admissions in adults in the United States.
    J Thorac Cardiovasc Surg. 2025 Oct 13:S0022-5223(25)00872.
    PubMed     Abstract available


    June 2025
  2. OHMORI T, Hiraoka A, Hamada Y, Kishimoto S, et al
    Long-term Prognostic Value of HFA-PEFF Score in Patients Undergoing Isolated Surgical Aortic Valve Replacement for Severe Aortic Stenosis.
    J Thorac Cardiovasc Surg. 2025 Jun 25:S0022-5223(25)00541.
    PubMed     Abstract available


  3. OVERBEY DM, Kucera JA, Aykut B, Wolf SE, et al
    Pediatric Heart Transplant in Donation After Circulatory Death using Normothermic Regional Perfusion.
    J Thorac Cardiovasc Surg. 2025 Jun 20:S0022-5223(25)00535.
    PubMed     Abstract available


    April 2025
  4. DAVIES RR, Iqbal M, Lantz-Thomason J, Carrington S, et al
    Paracorporeal continuous flow ventricular assist devices (cfvads) for children < 20 kg: Challenging the paradigm in the smallest patients.
    J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00323.
    PubMed     Abstract available


  5. MULLIS DM, Garrison A, Heng E, Zhu Y, et al
    Heart-liver transplantation using the en bloc technique: A single-center experience over two decades.
    J Thorac Cardiovasc Surg. 2025;169:1254-1262.
    PubMed     Abstract available


    February 2025
  6. REBOLLEDO MA, Knott-Craig CJ, Corson AH, Phillip R, et al
    Right Ventricular Endomyocardial Fibrosis with an Unguarded Tricuspid Valve - Surgical Management of a 9-year-old with Severe Right Heart Failure.
    J Thorac Cardiovasc Surg. 2025 Feb 4:S0022-5223(25)00096.
    PubMed    


  7. MOELLER CM, Rubinstein G, Oren D, Valledor AF, et al
    Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center.
    J Thorac Cardiovasc Surg. 2025;169:650-657.
    PubMed     Abstract available


    September 2024
  8. NORDAN T, Keshk M, Hackmann A, Givertz MM, et al
    The Impact of Blood Type and Body Size on Successful Bridging to Heart Transplantation using Intraaortic Balloon Pump or Surgically Implanted Microaxial Left Ventricular Assist Device.
    J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00835.
    PubMed     Abstract available


  9. PLA MM, Russell SD, Milano CA, Chiang Y, et al
    Late Follow-up for a Randomized Trial of Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation.
    J Thorac Cardiovasc Surg. 2024 Sep 21:S0022-5223(24)00830.
    PubMed     Abstract available


  10. MOROI MK, Patel K, Rajesh K, Lin A, et al
    Early Outcomes in Heart Transplantation using Donation after Circulatory Death Donors in Patients Bridged with Durable Left Ventricular Assist Devices.
    J Thorac Cardiovasc Surg. 2024 Sep 9:S0022-5223(24)00788.
    PubMed     Abstract available


  11. BRLECIC PE, Ghanta RK
    Commentary: Building bridges to recovery in patients with ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;168:e89-e90.
    PubMed    


  12. HEIMA D, Takeda M, Tabata Y, Minatoya K, et al
    Therapeutic potential of human induced pluripotent stem cell-derived cardiac tissue in an ischemic model with unloaded condition mimicking left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;168:e72-e88.
    PubMed     Abstract available


    August 2024

  13. Discussion to: Outcome of patients supported with HeartMate 3 after extracorporeal life support: On behlaf of the Durable Mechanical Circulatory Support After Extracorporeal Life Support Study Group.
    J Thorac Cardiovasc Surg. 2024;168:579-580.
    PubMed    


    July 2024

  14. Discussion to: Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:145-146.
    PubMed    


  15. TANG PC, Millar J, Noly PE, Sicim H, et al
    Preoperative passive venous pressure-driven cardiac function determines left ventricular assist device outcomes.
    J Thorac Cardiovasc Surg. 2024;168:133-144.
    PubMed     Abstract available


    June 2024
  16. NGUYEN A, Schaff HV
    Is Transplantation the Only Option for Diastolic Heart Failure?
    J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00525.
    PubMed    


  17. GUZMAN-GOMEZ A, Greenberg JW, Dani A, Villa C, et al
    In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
    J Thorac Cardiovasc Surg. 2024;167:2206-2214.
    PubMed     Abstract available


  18. MOVAHEDI F, Pagani FD, Antaki JF
    In search of similarity in adverse events journeys of patients with left ventricular assist devices.
    J Thorac Cardiovasc Surg. 2024;167:2147-2156.
    PubMed     Abstract available


    May 2024
  19. HYNDS MA, Hayashi H, Kurlansky P, Zhao Y, et al
    Medium-Term Outcomes of Concomitant Aortic Valve Repair in Patients with Continuous-Flow Left Ventricular Assist Device.
    J Thorac Cardiovasc Surg. 2024 May 25:S0022-5223(24)00447.
    PubMed     Abstract available



  20. Discussion to: Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1564-1565.
    PubMed    


  21. GREENBERG JW, Kulshrestha K, Guzman-Gomez A, Fields K, et al
    Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant.
    J Thorac Cardiovasc Surg. 2024;167:1556-1563.
    PubMed     Abstract available


  22. KONSTANTINOV IE, Davies B
    Durable ventricular assist device implantation in a child after double switch operation.
    J Thorac Cardiovasc Surg. 2024;167:1566-1569.
    PubMed    


  23. SILVESTRY SC
    Commentary: Tricuspid repair and left ventricular assist device: A new baseline.
    J Thorac Cardiovasc Surg. 2024;167:1821-1822.
    PubMed    


  24. SIMPSON MT, Ning Y, Kurlansky P, Colombo PC, et al
    Outcomes of treatment for deep left ventricular assist device infection.
    J Thorac Cardiovasc Surg. 2024;167:1824-1832.
    PubMed     Abstract available


    April 2024
  25. SAKURAI Y, Mehaffey JH, Kuno T, Yokoyama Y, et al
    The impact of permanent pacemaker implantation on long-term survival following cardiac surgery; A systematic review and meta-analysis.
    J Thorac Cardiovasc Surg. 2024 Apr 22:S0022-5223(24)00368.
    PubMed     Abstract available


  26. BLEIWEIS MS, Philip J, Peek GJ, Jacobs JP, et al
    Commentary: Challenges associated with long-term implantable ventricular assist device support in children.
    J Thorac Cardiovasc Surg. 2024;167:1429-1430.
    PubMed    


  27. WERT L, Stewart GC, Mehra MR, Milwidsky A, et al
    A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device.
    J Thorac Cardiovasc Surg. 2024;167:1322-1330.
    PubMed     Abstract available


    March 2024
  28. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
    Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
    J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
    PubMed     Abstract available


  29. AZIZGOLSHANI N, Takeda K
    Commentary: What is the destination after left ventricular assist device under the new heart allocation system?
    J Thorac Cardiovasc Surg. 2024;167:1060-1061.
    PubMed    


    February 2024
  30. GOSEV I, Pham DT, Um JY, Anyanwu AC, et al
    Ventricular Assist Device using a Thoracotomybased Implant Technique: Multi-center HeartMate 3 SWIFT Study.
    J Thorac Cardiovasc Surg. 2024 Feb 15:S0022-5223(24)00179.
    PubMed     Abstract available


  31. SINGH SK, Hassanein M, Ning Y, Wang C, et al
    Increasing waiting times for status 2 patients in new United Network for Organ Sharing allocation system: Impact on waitlist and posttransplant outcomes.
    J Thorac Cardiovasc Surg. 2024;167:535-543.
    PubMed     Abstract available


  32. VINOGRADSKY A, Ning Y, Kurlansky P, Kirschner M, et al
    Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy.
    J Thorac Cardiovasc Surg. 2024;167:731-743.
    PubMed     Abstract available


  33. DIMAGLI A, Worku B, Gaudino M
    Commentary: Minimally invasive left ventricular assist device implantation: Did we forget the valve?
    J Thorac Cardiovasc Surg. 2024;167:744-745.
    PubMed    


    January 2024
  34. ITAGAKI S, Toyoda N, Egorova N, Sun E, et al
    Total artificial heart implantation as a bridge to transplantation in the United States.
    J Thorac Cardiovasc Surg. 2024;167:205-214.
    PubMed     Abstract available


    December 2023
  35. KIRSCHNER M, Topkara VK, Sun J, Kurlansky P, et al
    Comparing 3-Year Survival and Readmissions between HeartMate 3 and Heart Transplant as Primary Treatment for Advanced Heart Failure.
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01207.
    PubMed     Abstract available



  36. Discussion to: Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.
    J Thorac Cardiovasc Surg. 2023 Dec 2:S0022-5223(23)01088.
    PubMed    


  37. TUME SC, Fuentes-Baldemar AA, Anders M, Spinner JA, et al
    Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.
    J Thorac Cardiovasc Surg. 2023;166:1756-1763.
    PubMed     Abstract available


  38. JOHN R, Kanwar MK, Cleveland JC Jr, Uriel N, et al
    Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial
    J Thorac Cardiovasc Surg. 2023;166:1684-1694.
    PubMed     Abstract available


    October 2023
  39. CHO J, Tunuguntla HP, Tume SC, Spinner JA, et al
    Long-term Implantable Ventricular Assist Device Support in Children.
    J Thorac Cardiovasc Surg. 2023 Oct 30:S0022-5223(23)01005.
    PubMed     Abstract available


  40. DECAMPLI WM
    Commentary: Is machine learning needed to understand that heart failure is a risk in adult congenital cardiac surgery?
    J Thorac Cardiovasc Surg. 2023 Oct 14:S0022-5223(23)00977.
    PubMed    


  41. FENG I, Wang AS, Takeda K, Topkara VK, et al
    Simultaneous Heart-Kidney Transplant Compared to Heart Transplant Alone in Non-Dialysis Dependent Patients with Borderline Renal Function.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00960.
    PubMed     Abstract available


  42. KONSTANTINOV IE, Brizard CP, Davies B
    Severe aortic valve insufficiency in infants on durable ventricular assist device support.
    J Thorac Cardiovasc Surg. 2023 Oct 12:S0022-5223(23)00914.
    PubMed    


  43. SCHUELER S, Bowles CT, Hinkel R, Wohlfarth R, et al
    A novel intrapericardial pulsatile device for individualized, biventricular circulatory support without direct blood contact.
    J Thorac Cardiovasc Surg. 2023;166:1119-1129.
    PubMed     Abstract available


  44. MOAZAMI N, Smith D
    Commentary: Direct cardiac compression device for biventricular support: If we put lipstick on a pig, is it still a pig?
    J Thorac Cardiovasc Surg. 2023;166:1130-1131.
    PubMed    


    September 2023
  45. GRIFFETH EM, Stephens EH, Dearani JA, Shreve JT, et al
    Impact of Heart Failure on Reoperation in Adult Congenital Heart Disease: An Innovative Machine Learning Model.
    J Thorac Cardiovasc Surg. 2023 Sep 28:S0022-5223(23)00871.
    PubMed     Abstract available


  46. SAEED D, Stark C, Otto W, Loforte A, et al
    Outcome of Patients supported with HeartMate 3 after Extra-corporeal Life Support. On behalf of Durable MCS after ECLS Study Group.
    J Thorac Cardiovasc Surg. 2023 Sep 7:S0022-5223(23)00763.
    PubMed     Abstract available


    August 2023
  47. KING CL, Onohara D, Tom SK, Silverman M, et al
    Transapical Ventricular Reshaping Reduces Functional Mitral Regurgitation and Improves Ventricular Function in a Preclinical Model of Ischemic Cardiomyopathy.
    J Thorac Cardiovasc Surg. 2023 Aug 17:S0022-5223(23)00724.
    PubMed     Abstract available


  48. ZHOU S, Yang G, Zhang M, Pienta M, et al
    Mortality following durable left ventricular assist device implantation by timing and type of first infection.
    J Thorac Cardiovasc Surg. 2023;166:570-579.
    PubMed     Abstract available


    July 2023
  49. MONGE MC, Joong A
    Commentary: Bridging the gap with temporary ventricular assist devices in pediatrics.
    J Thorac Cardiovasc Surg. 2023;166:212-213.
    PubMed    


    June 2023
  50. KULSHRESTHA K, Greenberg JW, Kennedy JT 3rd, Hogue S, et al
    National Experience with Pediatric Surgical Aortic Valve Repair - A Pediatric Health Information System Analysis.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00538.
    PubMed     Abstract available


  51. MALAS J, Chen Q, Emerson D, Gill G, et al
    Socioeconomic Disparities in Mid-Term Outcomes After Repair for Degenerative Mitral Regurgitation.
    J Thorac Cardiovasc Surg. 2023 Jun 27:S0022-5223(23)00534.
    PubMed     Abstract available


  52. LIU R, Li S, Yan J, Yan F, et al
    Fate of Transposition of the Great Arteries with Pulmonary Stenosis After Double-Root Translocation, Rastelli, and Reparation a l'Etage Ventriculaire.
    J Thorac Cardiovasc Surg. 2023 Jun 7:S0022-5223(23)00455.
    PubMed     Abstract available


  53. PIENTA MJ, Noly PE, Janda AM, Tang PC, et al
    Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device.
    J Thorac Cardiovasc Surg. 2023;165:2126-2131.
    PubMed    


  54. ELDE S, He H, Lingala B, Baiocchi M, et al
    Analysis of the revised heart allocation policy and the influence of increased mechanical circulatory support on survival.
    J Thorac Cardiovasc Surg. 2023;165:2090-2103.
    PubMed     Abstract available


  55. KILCOYNE MF, Blanding WM, Kilic A
    Commentary: Left ventricular assist device implantation and failure to rescue: New insights and familiar challenges.
    J Thorac Cardiovasc Surg. 2023;165:2124-2125.
    PubMed    


    April 2023
  56. MOVAHEDI F, Padman R, Antaki JF
    Limitations of receiver operating characteristic curve on imbalanced data: Assist device mortality risk scores.
    J Thorac Cardiovasc Surg. 2023;165:1433-1442.
    PubMed     Abstract available


    March 2023
  57. MANCINI D, Moss N
    Commentary: Bringing objectivity to the nonmedical evaluation of left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1123-1124.
    PubMed    


  58. YOUNG BAC, Tang PC
    Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?
    J Thorac Cardiovasc Surg. 2023;165:1125-1126.
    PubMed    


  59. OLT CK, Thuita LW, Soltesz EG, Tong MZ, et al
    Value of psychosocial evaluation for left ventricular assist device candidates.
    J Thorac Cardiovasc Surg. 2023;165:1111-1121.
    PubMed     Abstract available


  60. ROBERTSON G, Baran DA, Copeland H
    Commentary: In search of the "good candidate" for mechanical circulatory support.
    J Thorac Cardiovasc Surg. 2023;165:1122-1123.
    PubMed    


    January 2023
  61. PAGANI FD
    Commentary: Lack of benefit of tricuspid valve intervention with left ventricular assist device implantation? It's all in the details.
    J Thorac Cardiovasc Surg. 2023 Jan 21:S0022-5223(23)00084.
    PubMed    


    November 2022
  62. MENDIOLA PLA M, Chiang Y, Nicoara A, Poehlein E, et al
    Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial.
    J Thorac Cardiovasc Surg. 2022 Nov 16:S0022-5223(22)01243.
    PubMed     Abstract available


  63. CHO J, Fuentes-Baldemar AA, Tunuguntla HP, Spinner JA, et al
    Outcomes of temporary ventricular assist device: A pediatric institutional experience over 25 years.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01164.
    PubMed     Abstract available


  64. SILVESTRY SC
    Commentary: Left ventricular assist device complications after heart transplantation: Then and now.
    J Thorac Cardiovasc Surg. 2022 Nov 4:S0022-5223(22)01173.
    PubMed    


    August 2022
  65. EAPEN S, Nordan T, Critsinelis AC, Li B, et al
    Blood type O heart transplant candidates have longer waitlist time and higher delisting under the new allocation system.
    J Thorac Cardiovasc Surg. 2022 Aug 8. pii: S0022-5223(22)00826.
    PubMed     Abstract available


    February 2022
  66. KIM HR, Kim WK, Kim JK, Kim HJ, et al
    Prognostic impact of the E/e' ratio in patients with chronic severe aortic regurgitation undergoing aortic valve replacement.
    J Thorac Cardiovasc Surg. 2022 Feb 2. pii: S0022-5223(22)00114.
    PubMed     Abstract available


  67. BIANCO V, Kilic A, Yousef S, Serna-Gallegos D, et al
    The long-term impact of postoperative atrial fibrillation after cardiac surgery.
    J Thorac Cardiovasc Surg. 2022 Feb 1. pii: S0022-5223(22)00103.
    PubMed     Abstract available


    September 2021
  68. BRAHMBHATT DH, Rao V
    Commentary: Bridge to bridge: No longer a bridge too far for successful cardiac transplant.
    J Thorac Cardiovasc Surg. 2021 Sep 29. pii: S0022-5223(21)01393.
    PubMed    


  69. DUGGAL NM, Lei I, Wu X, Aaronson KD, et al
    Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures.
    J Thorac Cardiovasc Surg. 2021 Sep 14. pii: S0022-5223(21)01262.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.